Concepedia

Concept

prosthetic joint infections

Parents

9K

Publications

487.3K

Citations

29.6K

Authors

4.8K

Institutions

Biofilm-Driven Prosthetic Joint Infections

1970 - 1999

Prevention and management of prosthetic joint infections emerged as core research questions, linking environmental controls with antimicrobial strategies to curb deep infections after arthroplasty. Ultraclean operating room air and antibiotic-impregnated cement were central preventive measures, complemented by contamination-risk mitigation during surgery. For established infections, staged or staged-like exchange strategies dominated salvage efforts, with emphasis on long-term infection control and functional outcomes, while hematogenous and late infections highlighted delayed presentations requiring intervention and informing pathogenesis. Historical Significance: The period produced influential breakthroughs that shaped future directions, including the recognition of biofilm formation on implants as a driver of persistent prosthetic joint infections, guiding biomaterial and anti-biofilm research. Seminal work on ultraclean air conditions provided controlled evidence for reducing deep infections after hip and knee arthroplasty, influencing operating room design and infection-control protocols. Foundational studies on risk factors and management established thresholds for prevention and treatment, including the role of exchange arthroplasty in deep infections and the development of standardized perioperative infection prevention guidelines.

Prevention of prosthetic joint infection (PJI) emerges as a central theme, uniting environmental controls with antimicrobial strategies to curb deep infections after arthroplasty. Ultraclean operating room air, antibiotic-impregnated cement, and contamination-risk mitigation are repeatedly evaluated. [10], [20], [6], [3].

Management of established PJI emphasizes staged or staged-like surgical strategies for salvage of infected joints, including one-stage exchanges and two-stage reconstructions, with long-term functional outcomes and infection control. [2], [4], [8], [14], [19].

Hematogenous and late infections illuminate pathogenesis and natural history, with reports of hematogenous seeding of prostheses, long asymptomatic intervals, and subsequent deep infection requiring intervention. [5], [16], [13], [17].

Epidemiology and risk-factor patterns reveal incidence variability and patient factors across hip and knee arthroplasty, including prior surgery, ulcers, and rheumatic disease influencing infection risk. [1], [15], [12], [6].

Two-Stage Spacer Protocol

2000 - 2006

Prosthetic Joint Infection Diagnostics

2007 - 2013

Biofilm-Driven Prosthetic Joint Infection

2014 - 2016

Standardized Periprosthetic Joint Infection Management

2017 - 2023